
How This Luxury Cruise Line Is Leading The Way In Sustainable, Eco-Friendly Voyages
Given the havoc that mass travel can cause on the environment, Earth Month is the perfect time for travelers to consider the impact of where they go and how they get there.
Historically, the cruising industry has faced scrutiny due to its carbon footprint, massive waste output and aquatic disruption.
Fortunately, several cruise lines have modified their approach over the years by utilizing cutting-edge technology such as operating from battery power, revising their onboard disposable systems and transitioning to cleaner fuels.
Viking Cruise Lines stands out as a leader in balancing luxury with genuine sustainability. As a frontrunner in the clean maritime travel sector, Viking has overhauled its entire fleet of ocean liners to have minimal environmental impact and expeditions that prioritize preservation.
As of 2025, Viking has a fleet of over 90 ships, including larger luxury liners that accommodate 1,400 to 1,530 passengers and crew and smaller river vessels that can transport up to 638 passengers.
Viking's commitment to sustainable sailing begins with the installation of advanced sewage treatment systems on all 15 ships, preventing waste or bilge water from being discharged into the sea. According to Friends of Earth, all water from the vessel's toilets, showers and sinks is pumped ashore to municipal wastewater treatment plants. Their liners also operate on energy-efficient hybrid engines, hydrodynamically optimized hulls and solar panels to maximize fuel efficiency. Viking also equipped 12 of their ships with shoreside power capabilities to reduce port emissions.
Recently, Viking announced that in 2026, it would launch the Viking Libra, the world's first hydrogen-powered cruise ship capable of operating with zero emissions. In 2027, the brand will follow with a second hydrogen-powered ocean liner, the Viking Astrea.
Viking is among the first to commit to hydrogen-powered vessels—a leap from industry standards.
"From the outset, we have designed our river and ocean ships thoughtfully to reduce their fuel consumption and we are very proud the Viking Libra and the Viking Astrea will be even more environmentally friendly. Viking made the principled decision to invest in hydrogen which offers a true zero-emission solution. We look forward to welcoming the world's first hydrogen-powered cruise ship to our fleet in 2026.'
Along with its bold steps in environmental stewardship, Viking's Expedition cruises allow travelers to have first-hand experience in their attempt to prioritize preservation.
Launched in 2022, Viking Expedition ships the Viking Octantis and Viking Polaris are purpose-built state-of-the-art vessels that combine Scandinavian design, advanced technology and scientific discovery.
Each ship holds 378 guests and over 250 crew members, providing a unique blended experience of luxury, comfort and cultural enrichment.
Viking Expedition Ship—The Science Lab
Viking's expedition cruises are curated for curious travelers who want to explore some of the world's most remote and remarkable regions.
Expedition itineraries explore high-latitude and remote areas including Antarctica, the Arctic, the Great Lakes, Patagonia and beyond. Viking's experienced expedition team includes biologists, geologists, ornithologists and naturalists.
The onboard specialists guide the landings and shore excursions including studying phytoplankton and native coral, implementing bird-strike reduction efforts and discovering new penguin colonies.
Viking guests watching gentoo penguins during onshore excursions in Antarctica.
Guests are encouraged to participate in designated science programs such as collecting water samples, launching weather balloons and viewing research conducted in onboard labs. They are also encouraged to attend daily debriefings and presentations of findings.
Viking's investment in cleaner travel has led them to create partnerships with leading institutions such as the University of Cambridge, UC San Diego Scripps Institution of Oceanography and the National Oceanic and Atmospheric Administration (NOAA).
Despite the integrated scientific aspect, Viking does not abandon their "luxury-first" approach on the expedition cruises. Guests will enjoy spacious staterooms featuring floor-to-ceiling views and ship amenities include world-class dining, a Scandinavian spa with a complimentary thermal suite and numerous lounges.
In an industry where the environmental impact is often open to criticism, Viking is sailing past the competition when it comes to investing in conservation methods and environmental stewardship.
Their impeccable eye for luxury, scientific collaborations and sustainable practices create an ideal environment for guests to experience both opulence and purpose.
Aboard Viking Cruises, guests are more than observers; they have the opportunity to actively participate in preserving our planet, redefining what it means to travel responsibly by sea.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Here's What Key Metrics Tell Us About Viking (VIK) Q2 Earnings
For the quarter ended June 2025, Viking Holdings (VIK) reported revenue of $1.88 billion, up 18.5% over the same period last year. EPS came in at $0.99, compared to $0.76 in the year-ago quarter. The reported revenue represents a surprise of +2.59% over the Zacks Consensus Estimate of $1.83 billion. With the consensus EPS estimate being $0.99, the company has not delivered EPS surprise. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Viking performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Occupancy: 95.6% compared to the 95% average estimate based on three analysts. Net Yield: $607.00 versus the three-analyst average estimate of $596.57. Capacity PCDs: 2,131,907.00 Days compared to the 2,120,194.00 Days average estimate based on three analysts. PCDs: 2,038,772.00 Days versus 2,015,924.00 Days estimated by three analysts on average. Onboard and other: $125.17 million compared to the $124.17 million average estimate based on five analysts. The reported number represents a change of +17.3% year over year. Cruise and land: $1.76 billion compared to the $1.71 billion average estimate based on five analysts. The reported number represents a change of +18.6% year over year. View all Key Company Metrics for Viking here>>> Shares of Viking have returned +3.9% over the past month versus the Zacks S&P 500 composite's +2.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viking Holdings Ltd. (VIK) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research


CNBC
a day ago
- CNBC
Stocks making the biggest moves midday: Home Depot, Intel, Viking Therapeutics, Nvidia and more
These are some of the stocks making the biggest moves in midday trading Tuesday. Viking Therapeutics — Shares tumbled 42% after phase 2 trial results showed Viking's experimental oral obesity drug had more side effects than expected. About 20% of the patients in the trial quit using the drug due to symptom such as nausea and vomiting. On average, patients lost 12% of their starting weight after 13 weeks. Target Hospitality — The temporary workforce housing play jumped around 6%. On Monday, Stifel upgraded Target Hospitality to buy from hold, dubbing it a "back door data center play" and lifting its target price to $11 from $7.50. The new target price suggests about 37% upside from Monday's close. Nvidia , Advanced Micro Devices and Palantir Technologies – Investors took profits in some of this year's high-flying tech stocks. Nvidia shares dropped nearly 3%, while AMD fell close to 5%. Palantir lost 7%. Strategy , Robinhood and Mara Holdings – Crypto-linked stocks dipped on Tuesday as bitcoin pulled back more than 2%. Bitcoin proxy Strategy and trading app maker Robinhood fell roughly 6% each. Bitcoin miners Mara Holdings and Riot Platforms lost more than 5% and 2%, respectively. UnitedHealth – The health insurance giant slid more than 2% following back-to-back winning days. The stock had seen a recent resurgence after Warren Buffett revealed a stake of 5 million shares in UnitedHealth, valued at about $1.6 billion. On Friday, the stock posted a nearly 12% advance for its best day since 2020. Intel — Shares of the chipmaker jumped more than 6% after it was announced that SoftBank will make a roughly $2 billion investment in the company, paying $23 per share for Intel's common stock. This comes as the U.S. government reportedly has been considering taking a stake in Intel. Palo Alto Networks — The cybersecurity stock gained more than 3% after the company's fiscal fourth-quarter results topped Wall Street's expectations. Palo Alto also posted better-than-expected guidance for the first quarter and full year and announced that its founder and chief technology officer, Nir Zuk, is retiring. Fabrinet — The electronic manufacturing services company dropped 10%. Fiscal fourth quarter adjusted earnings of $2.65 per share just barely beat the $2.64 per share that analysts polled by FactSet were expecting. Revenue of $909.7 million topped the consensus estimate of $883.1 million. Additionally, the company announced upbeat earnings and revenue guidance for the first quarter. Viking Holdings — Shares fell nearly 2% after the cruise operator posted its quarterly results. Viking's second-quarter adjusted earnings of 99 cents per share came in line with analysts' expectations, according to FactSet, while its revenue for the quarter of $1.88 billion beat the $1.85 billion that was anticipated. The company also said it plans to take delivery of six river vessels during the rest of this year. Best Buy — The consumer electronics retailer rose 3% following the launch of its third-party marketplace , which will expand its product offerings to shoppers. Xpeng — U.S. shares of the Chinese electric car startup popped 5% on the heels of the company posting a smaller-than-expected loss for the second quarter, per FactSet. Its revenue for the period also topped analysts' estimates. Tegna — Shares climbed 4%. Television broadcaster Nexstar Media and Tegna announced Tuesday that Nexstar has agreed to acquire Tegna for $3.54 billion . The deal is expected to close by the second half of next year. Home Depot — Shares of the home improvement retailer added 3%. Despite the company missing on both lines for the first time since 2014, it maintained its full-year outlook. — CNBC's Alex Harring, Michelle Fox Theobald, Sean Conlon and Christina Cheddar Berk contributed reporting.
Yahoo
a day ago
- Yahoo
Viking Therapeutics Stock Plunges on Oral Weight-Loss Pill Study Results
Key Takeaways Viking Therapeutics reported a large number of patients dropped out of a study of its experimental weight-loss pill. Overall, 28% of those taking VK2735 left the Phase 2 trial early compared with 18% among placebo subjects. The research showed the pill reduced the weight of patients who took it for 13 weeks by up to 26.7 pounds. Viking Therapeutics (VKTX) shares cratered nearly 45% Tuesday when the biopharma firm reported study of its experimental weight-loss pill raised concerns about side effects. The company said a Phase 2 trial of its VK2735 tablet found that patients lost up to 12.2% of their mean body weight, or about 26.7 pounds, compared to a drop of 1.3% mean body weight, or 2.9 pounds, for those given a placebo. However, overall 28% of those on VK2735 stopped taking it early, while only 18% of the placebo group did so. Viking said the most common reason for patients discontinuing the treatment was "gastrointestinal (GI)-related adverse events." CEO Brian Lian said in a call with analysts that the number of adverse effects were highest in the first week of the trial, and declined as it went on. He explained that "GI-related adverse event rates might be further reduced through lower starting doses and or slower dose escalation," according to a transcript provided by AlphaSense. Lian added the company looks forward to "exploring this further in an upcoming maintenance dosing study." Today's plunge sent shares of Viking Therapeutics down nearly 40% the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data